Immunome, Inc. (IMNM) vs Lakefront Biotherapeutics - Sponsored ADR (LKFT)
- Immunome, Inc. IMNM 16.47 −5.34%
- Lakefront Biotherapeutics - Sponsored ADR LKFT 29.90 −0.10%
Immunome, Inc. and Lakefront Biotherapeutics - Sponsored ADR are both Biotechnology companies. Immunome, Inc. and Lakefront Biotherapeutics - Sponsored ADR are of similar size ($2.1B and $2.0B). Immunome, Inc. grew revenue faster over the last twelve months: 16.7% against −52.2%. Immunome, Inc. has the higher net margin (0.00% vs −6.81%) and the lower return on invested capital (−3,323.0% vs 0.00%). Across the 16 metrics below, Lakefront Biotherapeutics - Sponsored ADR leads on 10 and Immunome, Inc. on 6.
Valuation
Profitability
| Metric | IMNM | LKFT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 89.75% | 65.16% |
| Operating margin | 0.00% | (90.11%) | 0.00% |
| Net margin | 0.00% | (6.81%) | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (64.03%) | 0.00% | (56.36%) |
| Return on assets | (59.03%) | 0.00% | (48.04%) |
| Return on invested capital | (3,322.99%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack